Opportunity Information: Apply for CDC RFA PS12 1208
Apply for CDC RFA PS12 1208
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Serve as the U.S. partner within the global STOP TB Partnership and participate in Stop TB Partnership activities." and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.947 Tuberculosis Demonstration, Research, Public and Professional Education.
- This funding opportunity was created on Apr 1, 2012 and posted on Apr 1, 2012.
- Applicants must submit their applications by May 31, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Eligible applicants that can apply for this funding opportunity are listed below Public, non profit organizations Private, non profit organizations For profit organizations Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized Indian tribal Governments Indian tribes Indian tribal organizations U.S. State and local Governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of U.S. States (in consultation with States) A Bona Fide Agent is an agency/organization identified by a state as eligible to submit an application under the States eligibility in lieu of a State application. If applying as a bona fide agent of a State or local Government, a letter from the State or local Government as documentation of the status is required. Place this documentation behind the first page of the application form.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (RFA CDC RFA PS12-1208) supports a single U.S. recipient that will serve as the administrative and operational hub for the STOP TB USA partnership, the U.S.-based counterpart to the global Stop TB Partnership. The award is structured as a cooperative agreement, meaning the recipient is expected to work closely with CDC rather than operate entirely independently. The core idea is not to fund direct clinical services, but to fund the backbone functions that keep a national partnership active and effective, including coordination, communication, and organized participation in Stop TB Partnership activities.
The purpose of STOP TB USA under this announcement is to build and sustain a broad social movement around tuberculosis elimination in the United States. The program is intended to elevate TB as an ongoing public health priority by combining public awareness efforts, community empowerment, and policy-focused action. The recipient is expected to help mobilize and support resources for TB elimination at every level of the public health system: national, state, and local. This includes helping partners align around shared goals, encouraging investment and engagement, and keeping TB elimination visible in policy and funding discussions, especially in settings where TB can be overlooked due to relatively low overall incidence compared with other diseases.
A major function of the funded partner is to serve as a trusted channel for scientific and public health information about TB elimination. That includes translating and disseminating knowledge to policymakers and the general public about the status of TB elimination globally and within the U.S., including state and local perspectives. In practice, this implies maintaining clear, accessible messaging and materials that reflect current evidence and public health realities, and ensuring that decision-makers and communities understand both progress and remaining gaps. This role is especially relevant because TB elimination is influenced by global trends, migration patterns, drug resistance, and social determinants of health, so policymakers often need context that bridges local concerns with global TB dynamics.
The opportunity also emphasizes educating policymakers and the public about why sustained community public health activities are necessary to eliminate TB. This includes reinforcing the importance of ongoing prevention and control work even when case numbers are relatively low, since TB can rebound if infrastructure and vigilance weaken. The announcement explicitly notes the need for new tools as part of elimination, which signals attention to innovation such as improved diagnostics, treatments, and prevention approaches, as well as better strategies for finding and supporting affected populations. The recipient would be expected to support messaging and engagement that helps maintain long-term commitment to these efforts.
Another central requirement is creating a framework that increases community participation in national TB elimination efforts, with specific emphasis on awareness and involvement among at-risk populations. This suggests that the funded partnership should not operate only at a professional or governmental level; it should also help create meaningful ways for communities to participate, shape priorities, and access understandable information. The focus on at-risk populations underscores an expectation that outreach and engagement will address populations disproportionately impacted by TB and those facing barriers to prevention, diagnosis, or treatment.
In terms of funding and scale, CDC anticipated making one award, with an estimated total funding amount of $500,000 for the opportunity. The listed award ceiling and floor are both $100,000, indicating an expected annual award amount of $100,000 (the larger total likely reflects a multi-year project period typical of cooperative agreements). There is no cost sharing or matching requirement, which can lower barriers for organizations that may not have flexible funds to contribute.
Eligibility is broad and includes public and private nonprofit organizations, for-profit organizations (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based and faith-based organizations, federally recognized tribal governments and tribal organizations, and U.S. state and local governments or bona fide agents. Applicants seeking to apply as a bona fide agent for a state or local government must provide documentation (a letter) confirming that status as part of the application package.
Administratively, the opportunity was posted April 1, 2012, with an original and final closing date of May 31, 2012, and it was archived June 30, 2012. The CFDA program associated with this funding is 93.947, Tuberculosis Demonstration, Research, Public and Professional Education. For application or access issues, the announcement directs applicants to CDC’s Procurement and Grants Office (PGO) via phone (770-488-2006) or email (pgotim@cdc.gov).
Frequently Asked Questions (FAQs)
What is the name and reference number of this CDC funding opportunity?
This opportunity is a CDC funding announcement titled RFA CDC RFA PS12-1208.
What is the program being funded under this announcement?
The award supports STOP TB USA, described as the U.S.-based counterpart to the global Stop TB Partnership.
How many awards does CDC anticipate making?
CDC anticipated making one award under this opportunity.
What is the recipient expected to do?
The recipient is expected to serve as the administrative and operational hub (the backbone organization) for the STOP TB USA partnership. Core functions described include coordination, communication, and organizing participation in Stop TB Partnership activities.
Is this funding intended to pay for direct clinical TB services?
No. The announcement emphasizes that the core idea is not to fund direct clinical services, but to fund the backbone functions that keep a national partnership active and effective (for example, coordination and communication).
What type of award is this?
The award is structured as a cooperative agreement, meaning the recipient is expected to work closely with CDC rather than operate entirely independently.
What is the overall purpose of STOP TB USA under this announcement?
The purpose is to build and sustain a broad social movement around tuberculosis elimination in the United States by elevating TB as an ongoing public health priority through public awareness efforts, community empowerment, and policy-focused action.
What kinds of activities does the announcement highlight as important?
The announcement highlights backbone partnership work such as coordinating partners around shared goals, maintaining communications, supporting organized participation in Stop TB Partnership activities, educating policymakers and the public, and keeping TB elimination visible in policy and funding discussions.
What does "mobilize and support resources for TB elimination" mean in this context?
Based on the description provided, it means helping support TB elimination efforts at national, state, and local levels by aligning partners around shared goals, encouraging investment and engagement, and elevating TB elimination in policy and funding discussions, including settings where TB may be overlooked due to relatively low overall incidence.
What role does scientific and public health information play in this project?
A major function described is to serve as a trusted channel for scientific and public health information about TB elimination. This includes translating and disseminating knowledge to policymakers and the general public about TB elimination status globally and in the U.S., including state and local perspectives.
Why does the announcement emphasize connecting local TB work with global TB dynamics?
The description notes that TB elimination is influenced by global trends, migration patterns, drug resistance, and social determinants of health. Because of that, policymakers often need context that bridges local concerns with global TB dynamics.
Does the announcement address the risk of TB being deprioritized when case counts are low?
Yes. The opportunity emphasizes educating policymakers and the public about why sustained community public health activities are necessary even when case numbers are relatively low, noting TB can rebound if infrastructure and vigilance weaken.
Does the opportunity mention innovation or new tools?
Yes. The announcement explicitly notes the need for new tools as part of elimination, signaling attention to innovation such as improved diagnostics, treatments, and prevention approaches, as well as better strategies for finding and supporting affected populations.
What does the announcement say about community participation?
It requires creating a framework that increases community participation in national TB elimination efforts, with specific emphasis on awareness and involvement among at-risk populations.
Are at-risk populations specifically mentioned?
Yes. The announcement emphasizes awareness and involvement among at-risk populations and suggests outreach and engagement should address populations disproportionately impacted by TB and those facing barriers to prevention, diagnosis, or treatment.
How much funding is available?
CDC estimated a total funding amount of $500,000 for the opportunity.
What are the award ceiling and floor?
The listed award ceiling is $100,000 and the listed award floor is also $100,000.
What annual award amount does the funding description suggest?
Because both the ceiling and floor are listed as $100,000, the description indicates an expected annual award amount of $100,000. The larger estimated total ($500,000) likely reflects a multi-year project period typical of cooperative agreements.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad and includes public and private nonprofit organizations; for-profit organizations (including small, minority-, and women-owned businesses); universities and colleges; research institutions; hospitals; community-based and faith-based organizations; federally recognized tribal governments and tribal organizations; and U.S. state and local governments or bona fide agents.
What is a "bona fide agent" and is any documentation required?
The announcement states that applicants seeking to apply as a bona fide agent for a state or local government must provide documentation (a letter) confirming that status as part of the application package.
When was the opportunity posted and when did it close?
The opportunity was posted on April 1, 2012. The original closing date was May 31, 2012, and the final closing date was also May 31, 2012.
Is this opportunity still open?
No. The opportunity was archived on June 30, 2012.
What CFDA program is associated with this funding?
The CFDA program associated with this funding is 93.947, titled "Tuberculosis Demonstration, Research, Public and Professional Education."
Who should applicants contact for application or access issues?
For application or access issues, the announcement directs applicants to CDC's Procurement and Grants Office (PGO) by phone at 770-488-2006 or by email at pgotim@cdc.gov.
Does the description specify what kinds of communication products or messages are expected?
It indicates the recipient should maintain clear, accessible messaging and materials that reflect current evidence and public health realities, and ensure decision-makers and communities understand both progress and remaining gaps in TB elimination.
Does the partnership focus only on professionals and government agencies?
No. The description suggests STOP TB USA should not operate only at a professional or governmental level. It should also create meaningful ways for communities to participate, shape priorities, and access understandable information.
Browse more opportunities from the same category: Health
Next opportunity: Climate Resilient Ecosystems and Livelihoods (CREL)
Previous opportunity: Comprehensive Facility Based Technical Assistance in the Context of Health Systems Strengthening in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS12 1208
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS12 1208) also looked into and applied for these:
| Funding Opportunity |
|---|
| Genomic Medicine Pilot Demonstration Projects Coordinating Center (U01) Apply for RFA HG 12 007 Funding Number: RFA HG 12 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genomic Medicine Pilot Demonstration Projects (U01) Apply for RFA HG 12 006 Funding Number: RFA HG 12 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) Apply for PAR 12 152 Funding Number: PAR 12 152 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of a Vestibular Neural Prosthesis (R01) Apply for RFA DC 13 001 Funding Number: RFA DC 13 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Comprehensive District Based Support for Better HIV/TB Patient Outcomes Apply for RFA 674 12 000005 DRAFT RFA Funding Number: RFA 674 12 000005 DRAFT RFA Agency: South Africa USAID Pretoria Category: Health Funding Amount: $20,000,000 |
| Limited Competition NHLBI Research Centers at Minority Serving Institutions Phase II (P50) Apply for RFA HL 13 011 Funding Number: RFA HL 13 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Electronic Learning (E Learning) Collaborative Resource Center for SV and IPV Prevention Practitioners Apply for CDC RFA CE12 1204 Funding Number: CDC RFA CE12 1204 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $415,000 |
| Research and Technical Assistance for Public Health Laboratories in Haiti to support post earthquake reconstruction, cholera and HIV/AIDS response Apply for RFA GH 12 002 Funding Number: RFA GH 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Support Services for Orphans and Vulnerable Children in Nyanza and Rift Valley Provinces, Kenya, through Local Kenyan Organizations Apply for RFA 615 12 000004 Funding Number: RFA 615 12 000004 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $2,500,000 |
| Developing a Plan to Evaluate Delivery of Health Care Treatments and Services for Duchenne Muscular Dystrophy (DMD) Apply for CDC RFA DD12 1208 Funding Number: CDC RFA DD12 1208 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Surveillance of Congenital Heart Defects (CHDs) Focusing on Adolescents and Adults Apply for CDC RFA DD12 1207 Funding Number: CDC RFA DD12 1207 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| Short Term Research Education Program to Increase Diversity in Health Related Research (R25) Apply for RFA HL 13 020 Funding Number: RFA HL 13 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Support for Title V/Maternal and Child Health Oral Health Services Grant Program Apply for HRSA 12 059 Funding Number: HRSA 12 059 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition Revisions to Existing NIMH Supported Cooperative Agreement Awards (U01) Apply for PAR 12 154 Funding Number: PAR 12 154 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Nevada Washoe County) Apply for PA FPH 12 028 Funding Number: PA FPH 12 028 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $785,000 |
| Strengthening Surveillance for Diseases Among Newly Arrived Immigrants and Refugees Apply for CDC RFA CK12 1205 Funding Number: CDC RFA CK12 1205 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Continuing the Expansion of the Overseas Health Assessment and Management of U.S. Bound Refugees Apply for CDC RFA CK12 1207 Funding Number: CDC RFA CK12 1207 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Statewide Consumer Network Grant Apply for SM 12 002 Funding Number: SM 12 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Statewide Family Network Program Apply for SM 12 001 Funding Number: SM 12 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Integrative Omics Data Analysis for Discovery in Lung Diseases (R01) Apply for PAR 12 155 Funding Number: PAR 12 155 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS12 1208", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.